Product Comparison

Comparison Options

• Print
• Email
• Export Compare

McKesson #	796888	1193473	1056455
Description	Hylenex® Hyaluronidase, Human Recombinant, Preservative Free 150 Unit / mL Injection 1 mL	Hylenex® Hyaluronidase, Human Recombinant, Preservative Free 150 Unit / mL Injection 1 mL	Elitek® Rasburicase, Preservative Free 1.5 mg Injection 3 Vials
Manufacturer #	18657011704	1016120	00024515010
Brand	Hylenex®	Hylenex®	Elitek®
Manufacturer	Halozyme Inc	Healthfirst	Sanofi Pasteur
Invoice	HYLENEX, SDV 150U/1ML 1ML (4/CT)	HYLENEX, VL 150U/ML 1ML D/S	ELITEK, VL 1.5MG/ML (3/CT) RX
	Log In to Order	Log In to Order	Log In to Order
Comparison
Alternate Manufacturer Number	3465390
Alternate Packaging	CT/4	EA/1
Container Type	Single-Dose Vial	Single-Dose Vial	Single-Use Vial
Country of Origin	United States	United States	Unknown
Generic Drug Code	26665	26665	13228
Generic Drug Name	Hyaluronidase, Human Recombinant, Preservative Free	Hyaluronidase, Human Recombinant, Preservative Free	Rasburicase, Preservative Free
NDC Number	18657011704	51662155501	00024515010
Quantity			3 Vials
Storage Requirements	Requires Refrigeration	Requires Refrigeration
Strength	150 Unit / mL	150 Unit / mL	1.5 mg
Type			Intravenous
UNSPSC Code	51271503	51271503	51192014
Volume	1 mL	1 mL
Application	Enzyme	Enzyme	Enzyme
Dosage Form	Injection	Injection	Injection
Product Dating	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days
Features and Benefits	Hylenex recombinant (hyaluronidase human injection) is a tissue permeability modifier indicated as an adjuvant to increase the dispersion and absorption of other injected drugs HYLENEX recombinant (hyaluronidase human injection) for infiltration use, for interstitial use, for intramuscular use, for intraocular use, for peribulbar use, retrobulbar use, for soft tissue use and for subcutaneous use	Hylenex recombinant (hyaluronidase human injection) is a tissue permeability modifier indicated as an adjuvant to increase the dispersion and absorption of other injected drugs HYLENEX recombinant (hyaluronidase human injection) for infiltration use, for interstitial use, for intramuscular use, for intraocular use, for peribulbar use, retrobulbar use, for soft tissue use and for subcutaneous use	ELITEK® is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid ELITEK is indicated only for a single course of treatment One carton contains 3 single-dose vials each containing 1.5 mg of rasburicase and 3 ampules each containing 1 mL diluent